Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline
In the 5th edition of the WHO CNS tumor classification (CNS5, 2021), multiple molecular
characteristics became essential diagnostic criteria for many additional CNS tumor types …
characteristics became essential diagnostic criteria for many additional CNS tumor types …
[HTML][HTML] Molecular pathology of tumors of the central nervous system
BW Kristensen, LP Priesterbach-Ackley, JK Petersen… - Annals of oncology, 2019 - Elsevier
Since the update of the 4th edition of the WHO Classification of Central Nervous System
(CNS) Tumors published in 2016, particular molecular characteristics are part of the …
(CNS) Tumors published in 2016, particular molecular characteristics are part of the …
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Meningiomas are the most common primary intracranial tumors in adults and are increasing
in incidence due to the aging population and increased access to neuroimaging. While most …
in incidence due to the aging population and increased access to neuroimaging. While most …
Molecular alterations in meningioma: prognostic and therapeutic perspectives
The mutational landscape of meningioma has expanded following the use of the new
genetic sequencing approaches. Novel mutations have been characterized and reveal their …
genetic sequencing approaches. Novel mutations have been characterized and reveal their …
CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data
J Wach, AE Basaran, F Arlt, M Vychopen… - Acta Neuropathologica …, 2023 - Springer
Abstract Homozygous CDKN2A/B deletion has been associated with an increased risk of
recurrence in meningiomas. However, the evidence is confined to a limited number of …
recurrence in meningiomas. However, the evidence is confined to a limited number of …
Loss of H3K27me3 in meningiomas
Background There is a critical need for objective and reliable biomarkers of outcome in
meningiomas beyond WHO classification. Loss of H3K27me3 has been reported as a …
meningiomas beyond WHO classification. Loss of H3K27me3 has been reported as a …
SERPINH1 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis
Y Wang, W Gu, W Wen, X Zhang - Frontiers in genetics, 2022 - frontiersin.org
Background: Serpin peptidase inhibitor clade H, member 1 (SERPINH1) is a gene encoding
a member of the serpin superfamily of serine proteinase inhibitors. The upregulated of …
a member of the serpin superfamily of serine proteinase inhibitors. The upregulated of …
[HTML][HTML] Molecular characteristics of meningiomas
YS Lee, YS Lee - Journal of pathology and translational …, 2020 - synapse.koreamed.org
Meningioma is the most common primary intracranial tumor in adults. The grading of
meningioma is based on World Health Organization criteria, which rely on histopathological …
meningioma is based on World Health Organization criteria, which rely on histopathological …
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Homozygous deletion of CDKN2A/B was recently incorporated into the World Health
Organization classification for grade 3 meningiomas. While this marker is overall rare in …
Organization classification for grade 3 meningiomas. While this marker is overall rare in …
Dose-escalated radiation therapy is associated with improved outcomes for high-grade meningioma
Purpose The optimal modern radiation therapy (RT) approach after surgery for atypical and
malignant meningioma is unclear. We present results of dose escalation in a single …
malignant meningioma is unclear. We present results of dose escalation in a single …